GLP-1 Agonists (e.g., Tirzepatide, Semaglutide)

Supplement

Drugs predicted to emerge as geroprotectors due to their effects on glucose metabolism and satiety, noted for dramatically improving metabolic numbers in personal experimentation.

Mentioned in 1 video